OPTIMIZE Study | CSI360

OPTIMIZE – Follow-Up Phase

Optimize Clinical Study

OPTIMIZE is a prospective, randomized one to one (1:1), multi-center European pilot study designed to evaluate Orbital Atherectomy vessel preparation prior to drug coated balloons (DCBs) compared to DCB alone for the treatment of calcified below-the-knee lesions.

Study Design

  • Approximately 50 patients will be enrolled at up to 10 European sites and followed for up to 2 years
  • Late lumen loss at 6 months post-procedure will be an outcome measure

Other Studies

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.